Table 1.
Distribution of imaging findings amongst common Noninfectious pulmonary complications and statistics
| Imaging findings | Total no of patients (n = 46) | DS Group1 (n = 6) | DAH Group2 (n = 8) | Leukostasis Group3 (n = 14) | Pulmonary Leukemic infiltration Group 4 (n = 5) | Pulmonary edema Group5 (n = 13) | Group1 versus 2345 p-value | Group2 versus 1345 p-value | Group3 versus 1245 p-value | Group4 versus 1235 p-value | Group5 versus 1234 p-value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GGO | 35 | 6 (100%) | 8 (100%) | 10 (71.4%) | 0 (0%) | 11 (84.6%) | 0.3 | 0.1 | 0.7 | <0.001 | 0.4 |
| Consolidation | 7 | 0 (0%) | 2 (25%) | 3 (21.4%) | 0 (0%) | 2 (15.4%) | 0.5 | 0.5 | 0.6 | 0.9 | 0.9 |
| Interlobular sepal thickening | 17 | 2 (33.3%) | 0 (0%) | 1 (7.1%) | 2 (40.0%) | 12 (92.3%) | 0.9 | 0.01 | 0.007 | 0.9 | <0.001 |
| Nodules | 12 | 1 (16.7%) | 0 (0%) | 6 (42.9%) | 5 (100%) | 0 (0%) | 0.9 | 0.09 | 0.1 | 0.001 | 0.01 |
| Peribronchovascular interstitial thickening | 20 | 1 (16.7%) | 0 (0%) | 7 (50%) | 1 (20%) | 11 (84.6%) | 0.2 | 0.006 | 0.7 | 0.3 | 0.001 |
| Pleural effusion | 29 | 2 (33.3%) | 5 (62.5%) | 9 (64.3%) | 1 (20%) | 12 (92.3%) | 0.1 | 0.9 | 0.9 | 0.05 | 0.01 |
| Mediastinal lymphadenopathy | 8 | 0 (0%) | 2 (25%) | 2 (14.3%) | 2 (40.0%) | 2 (15.4%) | 0.5 | 0.6 | 0.9 | 0.2 | 0.9 |
DS differentiation syndrome, DAH diffuse alveolar hemorrhage
Bold values indicated statistically significant findings